Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Porter

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Nature Chemical Biology|June 5, 2012
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53Kelly D Sullivan, Nuria Padilla-Just, Ryan E Henry, et al.
Cancer Research|June 29, 2012
Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibitionMatias Casás-Selves, Jihye Kim, Zhiyong Zhang, et al.
Journal of Molecular Biology|June 9, 2009
Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin AJennifer Schlegel, Jasmina S Redzic, Christopher C Porter, et al.
Cancer Research|March 5, 2014
STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficaciousPaola Maycotte, Christy M Gearheart, Rebecca Barnard, et al.
Gene Therapy|August 13, 2021
Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cellsJaquelyn T Zoine, Chengyu Prince, Jamie Y Story, et al.
Oncotarget|February 25, 2016
Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancersHamid H Gari, Christy M Gearheart, Susan Fosmire, et al.
Nature Communications|May 2, 2025
Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlasHope L Mumme, Chenbin Huang, Denis Ohlstrom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Recommendations for Surveillance for Children with Leukemia-Predisposing ConditionsChristopher C Porter, Todd E Druley, Ayelet Erez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair DisordersMichael F Walsh, Vivian Y Chang, Wendy K Kohlmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer PredispositionSuzanne P MacFarland, Luke Maese, Surya P Rednam, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Nature Chemical Biology|June 5, 2012
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53Kelly D Sullivan, Nuria Padilla-Just, Ryan E Henry, et al.
Cancer Research|June 29, 2012
Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibitionMatias Casás-Selves, Jihye Kim, Zhiyong Zhang, et al.
Journal of Molecular Biology|June 9, 2009
Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin AJennifer Schlegel, Jasmina S Redzic, Christopher C Porter, et al.
Cancer Research|March 5, 2014
STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficaciousPaola Maycotte, Christy M Gearheart, Rebecca Barnard, et al.
Gene Therapy|August 13, 2021
Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cellsJaquelyn T Zoine, Chengyu Prince, Jamie Y Story, et al.
Oncotarget|February 25, 2016
Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancersHamid H Gari, Christy M Gearheart, Susan Fosmire, et al.
Nature Communications|May 2, 2025
Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlasHope L Mumme, Chenbin Huang, Denis Ohlstrom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Recommendations for Surveillance for Children with Leukemia-Predisposing ConditionsChristopher C Porter, Todd E Druley, Ayelet Erez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair DisordersMichael F Walsh, Vivian Y Chang, Wendy K Kohlmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer PredispositionSuzanne P MacFarland, Luke Maese, Surya P Rednam, et al.
Pageof 8